Ex Vivo Resection and Autotransplantation for Conventionally Unresectable Tumors – An 11-year Single Center Experience
- 21 August 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 272 (5), 766-772
- https://doi.org/10.1097/sla.0000000000004270
Abstract
Background and Aims: Ex vivo surgery may provide a chance at R0 resection for conventionally unresectable tumors. However, long-term outcomes have not been well documented. In this study, we analyze our 11-year outcomes to define its role. Study Design: We retrospectively analyzed 46 consecutive patients who underwent ex vivo surgery at our institution 2008–2019. Results: The types of tumors were: carcinoma (n = 20), sarcoma (n = 20) and benign to low grade tumor (n = 6). The type of ex vivo surgery was chosen based on tumor location and vascular involvement. The most commonly performed procedure was ex vivo hepatectomy (n = 18), followed by ex vivo resection and intestinal autotransplantation (n = 12), ex vivo Whipple procedure and liver autotransplantation (n = 8) and multivisceral ex vivo procedure (n = 7). Twenty-three patients (50%) are currently alive with median follow-up of 4.0-years (11 months–11.8 years). The overall survival was 70%/59%/52%, at 1-/3-/5-years, respectively. Patient survival for benign to low grade tumors, sarcoma, and carcinoma was 100%/100%/100%, 65%/60%/50%, and 65%/45%/40%, at 1-/3-/5-years, respectively. Ninety-one percent patients had R0 resection, and 57% had no recurrence to date with median follow-up of 3.1-years. Two patients (4.3%) died within 30 days due to sepsis and gastroduodenal artety (GDA) stump blowout. Two additional patients died between 30 and 90 days due to sepsis. Perioperative mortality in the last 23 consecutive cases was limited to 1 patient who died of sepsis between 30 and 90 days. Conclusions: For a selected group of patients with conventionally unresectable tumors, ex vivo surgery can offer effective surgical removal with a reasonably low perioperative mortality at experienced centers.Keywords
This publication has 27 references indexed in Scilit:
- Multivisceral Ex Vivo Surgery for Tumors Involving Celiac and Superior Mesenteric ArteriesAmerican Journal of Transplantation, 2012
- Primary leiomyosarcoma of the inferior vena cava: A 2-institution analysis of outcomesSurgery, 2012
- Extracorporeal Repair and Liver Autotransplantation after Total Avulsion of Hepatic Veins and Retrohepatic Inferior Vena Cava Injury Secondary to Blunt Abdominal TraumaThe Journal of Trauma and Acute Care Surgery, 2006
- Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinomaBritish Journal of Surgery, 2004
- Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesenteryJournal of the American College of Surgeons, 2003
- Ex vivo right trisegmentectomy with reconstruction of inferior vena cava and “flop” reimplantationJournal of the American College of Surgeons, 2002
- Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liverBritish Journal of Surgery, 1990
- Ex situ Operation an der Leber Eine neue Möglichkeit in der LeberchirurgieLangenbecks Archiv für Chirurgie, 1988
- RENAL TRANSPLANTATION IN MAN: Experience in 35 CasesThe Lancet, 1969
- Ex Situ Repair of Renal Artery for Renovascular HypertensionArchives of Surgery, 1967